BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 16705722)

  • 21. Preoperative concomitant boost intensity-modulated radiotherapy with oral capecitabine in locally advanced mid-low rectal cancer: a phase II trial.
    Li JL; Ji JF; Cai Y; Li XF; Li YH; Wu H; Xu B; Dou FY; Li ZY; Bu ZD; Wu AW; Tham IW
    Radiother Oncol; 2012 Jan; 102(1):4-9. PubMed ID: 21903285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preoperative radiotherapy with capecitabine and mitomycin C in locally advanced rectal carcinoma.
    Stojanovic S; Popov I; Radosevic-Jelic L; Micev M; Borojevic N; Nikolic V; Krivokapic Z; Kecmanovic D; Gavrilovic D; Kezic I
    Cancer Chemother Pharmacol; 2011 Sep; 68(3):787-93. PubMed ID: 21188380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Phase I study of postoperative concurrent chemoradiation with capecitabine as adjuvant treatment for stage II/III operable rectal cancer].
    Jin J; Li YX; Liu YP; Wang WH; Li T; Li N; Song YW
    Zhonghua Zhong Liu Za Zhi; 2006 May; 28(5):393-6. PubMed ID: 17045010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Phase I study of weekly intravenous oxaliplatin in combination with oral daily capecitabine and radiation therapy in the neoadjuvant treatment of rectal adenocarcinoma.
    Fakih MG; Rajput A; Yang GY; Pendyala L; Toth K; Smith JL; Lawrence DD; Rustum YM
    Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1462-70. PubMed ID: 16750332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Capecitabine initially concomitant to radiotherapy then perioperatively administered in locally advanced rectal cancer.
    Zampino MG; Magni E; Leonardi MC; Petazzi E; Santoro L; Luca F; Chiappa A; Petralia G; Trovato C; Fazio N; Orecchia R; Nolè F; de Braud F
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):421-7. PubMed ID: 19211200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of 5-fluorouracil/leucovorin and capecitabine in preoperative chemoradiotherapy for locally advanced rectal cancer.
    Kim DY; Jung KH; Kim TH; Kim DW; Chang HJ; Jeong JY; Kim YH; Son SH; Yun T; Hong CW; Sohn DK; Lim SB; Choi HS; Jeong SY; Park JG
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):378-84. PubMed ID: 17097835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preoperative chemoradiation with cisplatin and 5-fluorouracil for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, sphincter preservation.
    Valentini V; Coco C; Cellini N; Picciocchi A; Rosetto ME; Mantini G; Marmiroli L; Barbaro B; Cogliandolo S; Nuzzo G; Tedesco M; Ambesi-Impiombato F; Cosimelli M; Rotman M
    Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1175-84. PubMed ID: 10613310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Capecitabine plus oxaliplatin for the treatment of colorectal cancer.
    Carrato A; Gallego-Plazas J; Guillén-Ponce C
    Expert Rev Anticancer Ther; 2008 Feb; 8(2):161-74. PubMed ID: 18279056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preoperative long-course chemoradiation for localized rectal cancer: A retrospective comparison of response and outcome between 5-fluorouracil/leucovorin versus capecitabine.
    Kunheri B; Gurram B; Madhavan R; Makuny D
    Indian J Cancer; 2016; 53(4):518-523. PubMed ID: 28485342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiotherapy and oral capecitabine in the preoperative treatment of patients with rectal cancer: rationale, preliminary results and perspectives.
    Corvò R; Pastrone I; Scolaro T; Marcenaro M; Berretta L; Chiara S
    Tumori; 2003; 89(4):361-7. PubMed ID: 14606636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Capecitabine and radiotherapy as neoadjuvant treatment for rectal cancer.
    Ben-Josef E
    Am J Clin Oncol; 2007 Dec; 30(6):649-55. PubMed ID: 18091061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of 5-FU-based and Capecitabine-based Neoadjuvant Chemoradiotherapy in Patients With Rectal Cancer: A Meta-analysis.
    Zou XC; Wang QW; Zhang JM
    Clin Colorectal Cancer; 2017 Sep; 16(3):e123-e139. PubMed ID: 28284574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concurrent chemoradiation with capecitabine and weekly irinotecan as preoperative treatment for rectal cancer: results from a phase I/II study.
    Klautke G; Küchenmeister U; Foitzik T; Ludwig K; Prall F; Klar E; Fietkau R
    Br J Cancer; 2006 Apr; 94(7):976-81. PubMed ID: 16552435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bolus 5-Fluorouracil as an alternative modality to infusion 5-Fluorouracil in a patient with rectal cancer and capecitabine-induced cardiotoxicity.
    Shaib W; Lee V; Saif MW
    In Vivo; 2009; 23(5):821-6. PubMed ID: 19779118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ten years of preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, and sphincter preservation in three consecutive studies.
    Valentini V; Coco C; Cellini N; Picciocchi A; Fares MC; Rosetto ME; Mantini G; Morganti AG; Barbaro B; Cogliandolo S; Nuzzo G; Tedesco M; Ambesi-Impiombato F; Cosimelli M; Rotman M
    Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):371-83. PubMed ID: 11567811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparing pathological complete response rate using oral capecitabine versus infusional 5-fluorouracil with preoperative radiotherapy in rectal cancer treatment.
    Jootun N; Evans T; Mak J; Makin G; Platell C
    ANZ J Surg; 2018 Jan; 88(1-2):62-65. PubMed ID: 28982208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improving chemoradiotherapy in rectal cancer.
    Glynne-Jones R; Debus J
    Oncologist; 2001; 6 Suppl 4():29-34. PubMed ID: 11585972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preoperative chemoradiation in fixed distal rectal cancer: dose time factors for pathological complete response.
    Mohiuddin M; Regine WF; John WJ; Hagihara PF; McGrath PC; Kenady DE; Marks G
    Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):883-8. PubMed ID: 10705009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The integration of oral capecitabine into chemoradiation regimens for locally advanced rectal cancer: how successful have we been?
    Glynne-Jones R; Dunst J; Sebag-Montefiore D
    Ann Oncol; 2006 Mar; 17(3):361-71. PubMed ID: 16500912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evolution of 5-fluorouracil-based chemoradiation in the management of rectal cancer.
    Patel PA
    Anticancer Drugs; 2011 Apr; 22(4):311-6. PubMed ID: 21301320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.